Relief of Acute Lower Limb Ischemia with Percutaneous Fenestration of Intimal Flap in a Patient with Type III Aortic Dissection—A Case Report

Angiology ◽  
1993 ◽  
Vol 44 (9) ◽  
pp. 755-759 ◽  
Author(s):  
Noriyuki Kato ◽  
Hajime Sakuma ◽  
Kan Takeda ◽  
Tadanori Hirano ◽  
Tsuyoshi Nakagawa
VASA ◽  
2020 ◽  
pp. 1-6 ◽  
Author(s):  
Marina Di Pilla ◽  
Stefano Barco ◽  
Clara Sacco ◽  
Giovanni Barosi ◽  
Corrado Lodigiani

Summary: A 49-year-old man was diagnosed with pre-fibrotic myelofibrosis after acute left lower-limb ischemia requiring amputation and portal vein thrombosis. After surgery he developed heparin-induced thrombocytopenia (HIT) with venous thromboembolism, successfully treated with argatroban followed by dabigatran. Our systematic review of the literature supports the use of dabigatran for suspected HIT.


Leczenie Ran ◽  
2015 ◽  
Vol 12 (2) ◽  
pp. 59-67
Author(s):  
Paulina Mościcka ◽  
Maria T. Szewczyk ◽  
Elżbieta Hancke ◽  
Justyna Cwajda-Białasik ◽  
Paweł Wierzchowski ◽  
...  

2015 ◽  
Vol 10 (1) ◽  
pp. 28634 ◽  
Author(s):  
Ben Jmaà Hèla ◽  
Bouassida Abir ◽  
Gueldich Majdi ◽  
Dammak Aiman ◽  
Souissi Iheb ◽  
...  

2021 ◽  
Vol 50 (6) ◽  
pp. 405-409
Author(s):  
Kiyotaka Suzuki ◽  
Keiji Uchida ◽  
Tomoyuki Minami ◽  
Tomoki Cho ◽  
Yusuke Matsuki ◽  
...  

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Andrea Daprati ◽  
Andrea Garatti ◽  
Alberto Canziani ◽  
Alessandro Parolari

Author(s):  
Malik Azhar Hussain ◽  
Ramadan Alatawneh ◽  
Muhammad Omer Afzal Bhatti ◽  
Mohammad Akram Randhawa ◽  
Adnan Anwar ◽  
...  

2021 ◽  
Vol 8 (10) ◽  
pp. 3204
Author(s):  
Nishant Lal ◽  
Shafy Ali Khan ◽  
Aiswarya R. Pillai ◽  
Shafy Ali Khan

Though there have been multiple cases of arterial thrombosis and gangrene of limbs reported following COVID-19 infections, there has not been any case reported following COVID-19 vaccinations. Here we reported a case of acute lower limb ischemia following COVID-19 vaccination in a 32 year male with no co-morbidities. The clinical symptoms and signs related to lower limb ischemia started 2 weeks after COVID-19 vaccination. Despite anticoagulation, thrombo embolectomy and intraluminal catheter guided thrombolysis, patient’s left forefoot became gangrenous and had to be amputated.


Circulation ◽  
2015 ◽  
Vol 132 (suppl_3) ◽  
Author(s):  
Susan Alaei ◽  
Thoralf M Sundt ◽  
Udo Sechtem ◽  
Truls Myrmel ◽  
Marco Di Eusanio ◽  
...  

Background: This study assessed the incidence of lower limb ischemia as well as trends in management and outcomes while examining acute aortic dissection patients over a period of 15 years. Additionally, differences in clinical presentation, interventions performed, and mortality between patients with and without lower limb ischemia were investigated. Methods: Lower limb ischemia (LLI) was evaluated among 3812 patients enrolled in the International Registry of Acute Aortic Dissection over a 15-year period that was separated into three 5-year intervals: 1996-2001, 2002-2007, and 2008-2012. The cohort was then divided by dissection type and presence or absence of LLI. Results: Type A patients presenting with limb ischemia (N=280, 11.4%) were much more likely to have atherosclerosis (p=0.021) and to present with back, abdominal and leg pain versus chest pain (p<0.001 unless noted). Other symptoms of malperfusion, including ischemic spinal cord damage (p<0.001) and coma/altered consciousness (p=0.006) were more common in patients presenting with LLI. Surgery was less commonly performed in Type A LLI patients (79.3% vs 86.1%, p=0.002), a difference that did not change over time (p=0.453, trend p=0.479). Additionally, overall mortality was higher in LLI patients (37.5% vs 22.9%, p<0.001) and did not show improvement among the LLI cohort over time. Type B patients with LLI (N=102, 7.5%) were more likely to be current smokers (p=0.028), to present febrile (p=0.022), and to have leg pain (p<0.001). As with Type A, ischemic spinal cord damage was more common in the LLI cohort (p<0.001). Patients with LLI were much more likely to be managed with endovascular therapy (19.6% vs 50.0%, p<0.001) than with medication alone (66.5% vs 29.4%, p<0.001), with endovascular repair increasing in LLI patients over time (p=0.008, trend p=0.002). Again, overall mortality was higher in the LLI cohort (24.5% vs 9.7%, p<0.001) and did not change over time. Conclusions: Although Type B patients with LLI received more endovascular procedures in later years, overall mortality did not improve. Increased complications and higher mortality in the LLI cohort suggests a need for better monitoring and increased implementation of interventions in this population.


Sign in / Sign up

Export Citation Format

Share Document